- Provides a high dose of clinically relevant amounts of key nutrients, including 300 mg of CoQ10 and 1500 mg of Acetyl-L-carnitine
- Contains a combination of ancient peat and apple extracts shown to increase ATP levels, the primary currency of cellular energy, without increasing reactive oxygen species
- Antioxidant protection from superoxide dismutase and OpitacTM L-glutathione provides redox balance within the cell
- Suitable for vegetarians, with easy dosing and natural watermelon flavour
Serving Size: 1 heaping scoop (2.4 g)
|Acetyl-L-carnitine (N-acetyl L-carnitine hydrochloride)||1500 mg|
|Coenzyme Q10 (microorganism)||300 mg|
|Ancient Peat Extract||148.5 mg|
|Apple Extract 85:1 (Malus domestica) (fruit)||1.5 mg|
|OpitacTM L-glutathione||100 mg|
|Cucumis melo subsp. melo var. cantalupo (fruit)||2 mg|
|Superoxide Dismutase||140 IU|
|(from 10 mg Extramel®)|
Shellac gum, natural watermelon flavour, purified stevia leaf extract.
Does Not Contain
Contains no artificial colours, preservatives, or sweeteners; no dairy, sugar, wheat, gluten, soy, corn, egg, fish, shellfish, salt, tree nuts, or GMOs. Suitable for vegetarians.
Adults: 1 heaping scoop (2.4 g) per day dissolved in 250 ml of water or as directed by a health care practitioner. Take with food. Ensure you drink enough fluid before, during, and after exercise. Use a minimum of 4 weeks to see beneficial effects.
While no specific contraindication exists or is predicted, data is lacking for use during pregnancy, lactation, and in children, and the dosage may need to be reduced for those under the age of 18.
Although very little evidence supports this interaction, a potential interaction is possible for those taking the anticoagulant Coumadin and both CoQ10 and acetyl-l-carnitine. Close monitoring of the INR is recommended in these patients. No other negative drug interactions are known for CoQ10, though a number of medications inhibit CoQ10 synthesis or function in the body, including statin or blood pressure medications, tricyclic antidepressants, and oral hypoglycemic agents, suggesting a potential benefit of combined use.